Announcements and Notices - [Other - Business Update]

Antengene Corporation Limited operates as a specialty pharmaceutical company. The Company produces innovative drugs, selinexor, eltanexor, verdinexor, and other products. Antengene provides its services throughout China.

Voluntary Announcement
Xpovio Approved In Hong Kong For Two Additional
Indications In Multiple Myeloma And Diffuse Large B-Cell
Lymphoma

Voluntary Announcement
Ind Approval In China For Phase Ib/Ii Study Of
Atg-022 In Combination With Keytruda (Pembrolizumab) 
Chemotherapy

Financial Statements/ESG Information - [Interim/Half-Year Report]

2025 Interim Report

Next Day Disclosure Returns - [Share Buyback]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Voluntary Announcement Xpovio Approved In Hong Kong For Two Additional Indications In Multiple Myeloma And Diffuse Large B-Cell Lymphoma

Voluntary Announcement Ind Approval In China For Phase Ib/Ii Study Of Atg-022 In Combination With Keytruda (Pembrolizumab) Chemotherapy

2025 Interim Report

Next Day Disclosure Return

Next Day Disclosure Return